Christine M Barbon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization
    Christine M Barbon
    Dana Farber Cancer Institute, Boston, MA, USA
    Cell Immunol 262:150-61. 2010
  2. doi Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation
    Jeff K Davies
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cell Transplant 21:2047-61. 2012

Collaborators

Detail Information

Publications2

  1. doi Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization
    Christine M Barbon
    Dana Farber Cancer Institute, Boston, MA, USA
    Cell Immunol 262:150-61. 2010
    ..Thus, we report the synergistic activity of pharmacologic T(reg) depletion with cyclophosphamide on quantitatively and qualitatively increasing T cell responses to a known human tumor-associated antigen...
  2. doi Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation
    Jeff K Davies
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cell Transplant 21:2047-61. 2012
    ....